MedTrace Logo

Altered PSA Test Due to Possible Suspected Heterophilic Antibodies

NCT02455466 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-05-31

No results posted yet for this study

Summary

The purpose of this study is to investigate if clinically non explainable high or low Prostate-specific antigen (PSA) levels are associated with heterophilic antibodies in the serum of participants. The investigators will examine if heterophilic antibodies are the reasons of altered PSA levels.

Conditions

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-12-31
Completion
2016-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02455466 on ClinicalTrials.gov